Genmab — December 2023
-
Associate Director of Data Science at Genmab Sanyam Kumar: Harnessing AI To Revolutionize Healthcare https://www.outlookindia.com/business-spotlight/sanyam-kumar-harnessing-ai-to-revolutionize-healthcare-news-337605
-
US nøjedes med at miste 2,49% her til aften. Der blev en smule længere op til Jeres fantasimål
-
@Pensionisten….hvem er “Jeres”…
-
Jeg begiver mig ikke ud iden slags spådomme - det overlader jeg til de dygtige :-;
-
:-;
-
PS - facebook grupper holder jeg mig langt væk fra ……
-
First line submission filed: Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT
(amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) / MARIPOSA -
Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
/PRNewswire/ -- Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
(www.prnewswire.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind